Skip to content

Category Archives: Gastrointestinal surgery

Novel Gastrointestinal Interventional Therapies > Endolumenal application > GI Dynamics > Gut-Lining Device > Combats Diabetes > Obesity Clinical Trial > Reduced blood sugar > More invasive procedures might carry more risk > Harvard Medical School > Reversible > Device can be retrieved via the mouth > First World Congress on Interventional Therapies for Type 2 Diabetes > EndoBarrier Gastrointestinal Liner Data > Patients with Type 2 Diabetes > Presented at the First World Congress > Interventional Therapies for Type 2 Diabetes

Thursday, September 18, 2008

Has the EndoBarrier potential to provide immediate metabolic control with less risk? Are these the most exciting and promising device data from endoscopic devices? Has this disease has reached epidemic proportions around the globe? Is there a substantial unmet need for a simple and safe approach for patients to achieve metabolic control?

IIP > read on […]

Filed in Prospective randomized sham-controlled clinical trial, Clinical-stage medical device company, Deliver immediate metabolic control, Modifying metabolic pathways, Endoluminal Therapies for Type 2 Diabetes, Keynote lecture, Novel Gastrointestinal Interventional Therapies, Lee M Kaplan, Weight Center, Orally delivered, Removable device, Health policy makers, Public health authorities and insurers, Seize the opportunity, Novel interventional therapies, Forum for the medical community, Comprehensive and multidisciplinary forum, Lines a portion of the small intestine, Top-tier investors, Catalyst Health Ventures, Treat obesity and type 2 diabetes, Noninvasive device, Domain Associates, Johnson & Johnson Development Corporation, Polaris Venture Partners, Bariatric surgery, Cutlass Capital, Advanced Technology Ventures, New York Presbyterian Hospital, Weill Cornell Medical College, GI Dynamics, Type 2 diabetes, Clinical Trial, Patients with Type 2 Diabetes, First World Congress on Interventional Therapies, Pioneering new approaches to treating metabolic disorde, Medical Device Company, EndoBarrier Gastrointestinal Liner, Gastrointestinal surgery, Resulting in weight loss, Improved glycemic control, Massachusetts General Hospital | Comments Off

Prospective trial > Evaluating new circular and linear stapler > Gastrointestinal anastomosis > Commercial models of stapler devices > KYGW circular stapler > KYFB linear stapler > Changzhou Kangdi Medical Stapler > Chinese medical devices > Standard CDH circular and SDH linear staples, Ethicon Endo-Surgery > San Raffaele Scientific Institute Milan Italy

Monday, June 9, 2008

How does the ease of use, effectiveness and safety of the new stapling devices compare to U.S. models? Are the KYGW circular stapler and KYFB linear stapler from Changzhou Kangdi Medical Stapler comparable to Ethicon and Covidien devices? Are the anastomoses successfully completed without postoperative anastomotic fistula or dehiscence or do the Chinese staplers significantly […]

Filed in Experimental and control groups, Mean scores, Intra-abdominal sepsis, Leakage or intestinal obstruction, Colorectal anastomosis, Standard CDH circular and SDH linear staples, Instrument and anastomotic features, Surgical therapy for benign or malignant disease of the, Gastrointestinal anastomosis, Days to take fluid and normal diet, Length of hospital stay LOH, Anastomotic stenosis, Anastomotic lumen, Strictures, San Raffaele Scientific Institute Milan Italy, Gastrointestinal surgery, Chinese medical devices, Standard CDH circular staplers, SDH linear staples, Stapling devices, Changzhou Kangdi Medical Stapler, Conformity with clinical requirements, Use is simple and safe, KYGW circular stapler, KYFB linear stapler, Obesity is a complex condition, anastomosis, Body mass index of greater than 50, Morbid obesity, Surgical obesity intervention, Gastric bypass pouch and stoma reduction, Pouch enlargement or dilatation of the gastrojejunostom, Patients Who Gain Weight After Bariatric Surgery, Ethicon Endo-Surgery, Body mass index, Treatment Of Obesity, Obesity, Reduces Size of Stomach Pouch, Advances in the technology of healthcare, Metabolic Diseases, Diabetes is killing about 73,000 people in the U.S. eac, Other bariatric weight loss operations cost $25,000 in , Advanced Laparoscopic Procedures, Obesity Surgery, Advanced medical devices, LAGB banding costs $17,000 in the USA, Laparoscopic Adjustable Gastric Banding LAGB, Nutrition Disorders, Overweight, Overnutrition, Metabolic disorder, Risk factor obesity | Comments Off